Comparable safety and humoral immunogenicity of delayed versus delayed fractional boosting with blood-stage malaria RH5.1/Matrix-M vaccine

Holliday K., Nielsen CM., Roberts TW., Baker EC., Marshall B., Jarman C., Odongo I., Salkeld J., Diouf A., Marchevsky NG., Ashfield R., King LDW., Cowan RE., Lata P., Nugent FL., Cho J-S., Carnot C., Long CA., Hope P., Schutter J., Kay L., Winks T., Skinner K., Silk SE., Draper SJ., Minassian AM., Payne RO.

DOI

10.64898/2026.04.10.26348898

Type

Preprint

Publication Date

2026-04-14T00:00:00+00:00

Keywords

3207 Medical Microbiology, 32 Biomedical and Clinical Sciences, 3202 Clinical Sciences, Malaria Vaccine, Prevention, Orphan Drug, Vector-Borne Diseases, Biotechnology, Malaria, Clinical Trials and Supportive Activities, Immunization, Clinical Research, Rare Diseases, Infectious Diseases, Vaccine Related, Biodefense, Patient Safety, 3.4 Vaccines, 6.1 Pharmaceuticals, Infection, 3 Good Health and Well Being

Permalink More information Close